Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin Vascular Effects in T2DM
NCT01096277Phase 4Unknown
- Sponsor
- Hannover Medical School
- Start
- Oct 2010
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Hannover Medical School. Status: unknown.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01096277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01096277.